Singapore markets close in 4 hours 43 minutes

Swedish Orphan Biovitrum AB (publ) (BIOVF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
25.760.00 (0.00%)
At close: 09:52AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 8.79B
Enterprise value 10.52B
Trailing P/E 44.29
Forward P/E 27.70
PEG ratio (5-yr expected) 1.36
Price/sales (ttm)4.04
Price/book (mrq)2.65
Enterprise value/revenue 0.45
Enterprise value/EBITDA 1.44

Trading information

Stock price history

Beta (5Y monthly) 0.26
52-week change 39.18%
S&P500 52-week change 324.49%
52-week high 327.79
52-week low 318.35
50-day moving average 325.21
200-day moving average 322.83

Share statistics

Avg vol (3-month) 3156
Avg vol (10-day) 3400
Shares outstanding 5339.87M
Implied shares outstanding 6339.98M
Float 8198.7M
% held by insiders 110.08%
% held by institutions 173.76%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in SEK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 9.26%
Operating margin (ttm)23.47%

Management effectiveness

Return on assets (ttm)4.51%
Return on equity (ttm)6.72%

Income statement

Revenue (ttm)23.14B
Revenue per share (ttm)69.38
Quarterly revenue growth (yoy)19.40%
Gross profit (ttm)N/A
EBITDA 7.77B
Net income avi to common (ttm)2.14B
Diluted EPS (ttm)0.58
Quarterly earnings growth (yoy)-25.00%

Balance sheet

Total cash (mrq)527M
Total cash per share (mrq)1.55
Total debt (mrq)19.22B
Total debt/equity (mrq)53.54%
Current ratio (mrq)0.71
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)4.74B
Levered free cash flow (ttm)2.69B